Headed Back To School in 2023: A Look at Children’s Routine Vaccination Trends July 31, 2023 Issue Brief This issue brief examines the most recent trends in children’s routine vaccinations, including COVID-19, and explores what to watch as children head back to school this year.
How Do Dual-Eligible Individuals Get Their Medicare Coverage? July 31, 2023 Issue Brief People who are dually eligible for both Medicare and Medicaid coverage can get their Medicare coverage in a variety of ways. The brief breaks out the data for traditional Medicare, Medicare Advantage plans that are available to all Medicare beneficiaries, and plans that are designed specifically for dual-eligible beneficiaries.
Spending on Medicare Advantage Quality Bonus Payments Will Reach at Least $12.8 Billion in 2023 August 9, 2023 Issue Brief Annual bonus payments from the federal government to Medicare Advantage insurers have increased every year since 2015 and will reach at least $12.8 billion in 2023. Spending on bonus payments has grown faster than enrollment in Medicare Advantage plans.
Health Care Issues in the Early Stages of the 2024 Election July 20, 2023 Perspective In this JAMA Health Forum column, Larry Levitt examines differences in the Republican presidential candidates’ records and positions on health issues, including Medicaid and abortion, that could play a role in the primaries and would set up a sharp contrast in the general election against President Biden.
What are the Implications of New Anti-Obesity Drugs for Racial Disparities? July 24, 2023 Blog This policy watch discusses some of the potential implications of the new anti-obesity drugs for racial equity.
Key Facts About Medicare Part D Enrollment and Costs in 2023 July 26, 2023 Issue Brief The Medicare Part D program provides an outpatient prescription drug benefit to older adults and people with long-term disabilities in Medicare who enroll in private plans. This brief analyzes Medicare Part D enrollment and costs in 2023 and trends over time. The analysis highlights the substantial growth of Medicare Advantage drug plans in the marketplace for Part D drug coverage, where enrollment overall is concentrated in a handful of large plan sponsors.
A Closer Look at the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans July 6, 2023 Issue Brief This brief takes a closer look at the five largest publicly traded companies operating Medicaid MCOs which account for half of Medicaid MCO enrollment nationally. Information and data reported in this brief come from quarterly company earnings reports, financial filings, and other company materials as well as from national administrative data.
Addressing the Opioid Crisis: A Look at the Evolving Landscape of Federal OUD Treatment Policies July 11, 2023 Issue Brief Federal policies governing substance use disorder treatment have undergone rapid changes during the pandemic; however, the extent to which these changes can address the surge in opioid overdose deaths is unclear. Some of these policy adjustments are permanent, while others could revert to pre-pandemic regulations. In this brief, we examine the following 5 key federal policies and implications for access and treatment for OUD.
Amaya Diana July 6, 2023 Person Amaya Diana is a policy analyst with KFF’s Program on Medicaid and the Uninsured. In this role, she conducts research and policy analysis related to health insurance coverage and access to care for low-income populations, with a focus on Medicaid 1115 waiver activity. Prior to joining KFF, she was a…
Overview of Health Coverage and Care for Individuals with Limited English Proficiency (LEP) July 7, 2023 Issue Brief This brief analyzes 2021 American Community Survey data to highlight demographic, socioeconomic , and health coverage characteristics of individuals with limited English proficiency (LEP).